Occurrence of impaired fasting glucose in GH-deficient adults receiving GH replacement compared with untreated subjects

Clinical Endocrinology

Volumn 72, Issue 1, 2010, Pages 59-69

  Woodmansee, Whitney W ^a   Hartman, Mark L ^a   Lamberts, Steven W J ^b   Zagar, Anthony J ^a   Clemmons, David R ^c  

^a Lilly USA   (United States)

^b ERASMUS MEDICAL CENTER   (Netherlands)

^c UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESTRADIOL; GLUCOCORTICOID; GLUCOSE; GROWTH HORMONE; HEMOGLOBIN A1C; SOMATOMEDIN C; THYROID HORMONE; VASOPRESSIN;

ADULT; ANDROGEN THERAPY; ARTICLE; CLINICAL ASSESSMENT; CONTROLLED STUDY; DIABETES MELLITUS; DIET RESTRICTION; DRUG EFFECT; FEMALE; FOLLOW UP; GLUCOSE BLOOD LEVEL; GLUCOSE METABOLISM; GROWTH HORMONE DEFICIENCY; HEMOGLOBIN BLOOD LEVEL; HORMONE BLOOD LEVEL; HORMONE SUBSTITUTION; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SIDE EFFECT;

ADULT; ALGORITHMS; BLOOD GLUCOSE; DIABETES COMPLICATIONS; FASTING; FOLLOW-UP STUDIES; GLUCOSE INTOLERANCE; GROWTH DISORDERS; HEMOGLOBIN A, GLYCOSYLATED; HORMONE REPLACEMENT THERAPY; HUMAN GROWTH HORMONE; HUMANS; INCIDENCE; MIDDLE AGED; TIME FACTORS;

EID: 72249117360     PISSN: 03000664     EISSN: 13652265     Source Type: Journal    
DOI: 10.1111/j.1365-2265.2009.03612.x     Document Type: Article

References (34)

1. Attanasio, A.F., Lamberts, S.W., Matranga, A.M. et al. (1997) Adult growth hormone (GH)-deficient patients demonstrate heterogeneity between childhood onset and adult onset before and during human GH treatment. Journal of Clinical Endocrinology and Metabolism, 82, 82 88.
2. Hoffman, A.R., Kuntze, J.E., Baptista, J. et al. (2004) Growth hormone (GH) replacement therapy in adult-onset GH deficiency: effects on body composition in men and women in a double-blind, randomized, placebo-controlled trial. Journal of Clinical Endocrinology and Metabolism, 89, 2048 2056.
3. Jorgensen, J.O., Pedersen, S.A., Thuesen, L. et al. (1989) Beneficial effects of growth hormone treatment in GH-deficient adults. Lancet, 1, 1221 1225.
4. Salomon, F., Cuneo, R.C., Hesp, R. et al. (1989) The effects of treatment with recombinant human growth hormone on body composition and metabolism in adults with growth hormone deficiency. New England Journal of Medicine, 321, 1797 1803.
5. Simpson, H., Savine, R., Sonksen, P. et al. (2002) Growth hormone replacement therapy for adults: into the new millennium. Growth Hormone & IGF Research, 12, 1 33.
6. Chipman, J.J., Attanasio, A.F., Birkett, M.A. et al. (1997) The safety profile of GH replacement therapy in adults. Clinical Endocrinology, 46, 473 481.
7. Fowelin, J., Attvall, S., Lager, I. et al. (1993) Effects of treatment with recombinant human growth hormone on insulin sensitivity and glucose metabolism in adults with growth hormone deficiency. Metabolism, 42, 1443 1447.
8. O'Neal, D.N., Kalfas, A., Dunning, P.L. et al. (1994) The effect of 3 months of recombinant human growth hormone (GH) therapy on insulin and glucose-mediated glucose disposal and insulin secretion in GH-deficient adults: a minimal model analysis. Journal of Clinical Endocrinology and Metabolism, 79, 975 983.
9. Monson, J.P. (2003) Long-term experience with GH replacement therapy: efficacy and safety. European Journal of Endocrinology, 148 (Suppl 2 S9 S14.
10. Yuen, K.C. Dunger, D.B. (2006) Persisting effects on fasting glucose levels and insulin sensitivity after 6 months of discontinuation of a very low-dose GH therapy in adults with severe GH deficiency. Clinical Endocrinology, 64, 549 555.
11. Yuen, K.C. Dunger, D.B. (2007) Therapeutic aspects of growth hormone and insulin-like growth factor-I treatment on visceral fat and insulin sensitivity in adults. Diabetes, Obesity and Metabolism, 9, 11 22.
12. Yuen, K.C., Frystyk, J., White, D.K. et al. (2005) Improvement in insulin sensitivity without concomitant changes in body composition and cardiovascular risk markers following fixed administration of a very low growth hormone (GH) dose in adults with severe GH deficiency. Clinical Endocrinology, 63, 428 436. (Pubitemid 41442337)
13. Maison, P., Griffin, S., Nicoue-Beglah, M. et al. (2004) Impact of growth hormone (GH) treatment on cardiovascular risk factors in GH-deficient adults: a metaanalysis of blinded, randomized, placebo-controlled trials. Journal of Clinical Endocrinology and Metabolism, 89, 2192 2199.
14. Abs, R., Bengtsson, B.A., Hernberg-Stahl, E. et al. (1999) GH replacement in 1034 growth hormone deficient hypopituitary adults: demographic and clinical characteristics, dosing and safety. Clinical Endocrinology, 50, 703 713.
15. Hartman, M.L., Crowe, B.J., Biller, B.M. et al. (2002) Which patients do not require a GH stimulation test for the diagnosis of adult GH deficiency? Journal of Clinical Endocrinology and Metabolism, 87, 477 485.
16. American Diabetes Association (2008) Standards of medical care in diabetes - 2008. Diabetes Care, 31 (Suppl 1 S12 S54.
17. Biller, B.M., Samuels, M.H., Zagar, A. et al. (2002) Sensitivity and specificity of six tests for the diagnosis of adult GH deficiency. Journal of Clinical Endocrinology and Metabolism, 87, 2067 2079.
18. al-Shoumer, K.A., Gray, R., Anyaoku, V. et al. (1998) Effects of four years' treatment with biosynthetic human growth hormone (GH) on glucose homeostasis, insulin secretion and lipid metabolism in GH-deficient adults. Clinical Endocrinology, 48, 795 802.
19. Florakis, D., Hung, V., Kaltsas, G. et al. (2000) Sustained reduction in circulating cholesterol in adult hypopituitary patients given low dose titrated growth hormone replacement therapy: a two year study. Clinical Endocrinology, 53, 453 459.
20. Rosenfalck, A.M., Fisker, S., Hilsted, J. et al. (1999) The effect of the deterioration of insulin sensitivity on beta-cell function in growth-hormone-deficient adults following 4-month growth hormone replacement therapy. Growth Hormone & IGF Research, 9, 96 105.
21. Svensson, J., Fowelin, J., Landin, K. et al. (2002) Effects of seven years of GH-replacement therapy on insulin sensitivity in GH-deficient adults. Journal of Clinical Endocrinology and Metabolism, 87, 2121 2127.
22. Riedl, M., Ludvik, B., Pacini, G. et al. (2000) The increased insulin sensitivity in growth hormone-deficient adults is reduced by growth hormone replacement therapy. European Journal of Clinical Investigation, 30, 771 778.
23. Rosenfalck, A.M., Maghsoudi, S., Fisker, S. et al. (2000) The effect of 30 months of low-dose replacement therapy with recombinant human growth hormone (rhGH) on insulin and C-peptide kinetics, insulin secretion, insulin sensitivity, glucose effectiveness, and body composition in GH-deficient adults. Journal of Clinical Endocrinology and Metabolism, 85, 4173 4181.
24. Arwert, L.I., Roos, J.C., Lips, P. et al. (2005) Effects of 10 years of growth hormone (GH) replacement therapy in adult GH-deficient men. Clinical Endocrinology, 63, 310 316.
25. Giavoli, C., Porretti, S., Ronchi, C.L. et al. (2004) Long-term monitoring of insulin sensitivity in growth hormone-deficient adults on substitutive recombinant human growth hormone therapy. Metabolism, 53, 740 743.
26. Gotherstrom, G., Bengtsson, B.A., Bosaeus, I. et al. (2007) A 10-year, prospective study of the metabolic effects of growth hormone replacement in adults. Journal of Clinical Endocrinology and Metabolism, 92, 1442 1445.
27. Gotherstrom, G., Svensson, J., Koranyi, J. et al. (2001) A prospective study of 5 years of GH replacement therapy in GH-deficient adults: sustained effects on body composition, bone mass, and metabolic indices. Journal of Clinical Endocrinology and Metabolism, 86, 4657 4665.
28. Hoffman, D.M., O'Sullivan, A.J., Freund, J. et al. (1995) Adults with growth hormone deficiency have abnormal body composition but normal energy metabolism. Journal of Clinical Endocrinology and Metabolism, 80, 72 77.
29. Johannsson, G., Marin, P., Lonn, L. et al. (1997) Growth hormone treatment of abdominally obese men reduces abdominal fat mass, improves glucose and lipoprotein metabolism, and reduces diastolic blood pressure. Journal of Clinical Endocrinology and Metabolism, 82, 727 734. (Pubitemid 27106578)
30. van der Klaauw, A.A., Biermasz, N.R., Feskens, E.J. et al. (2007) The prevalence of the metabolic syndrome is increased in patients with GH deficiency, irrespective of long-term substitution with recombinant human GH. European Journal of Endocrinology, 156, 455 462.
31. Molitch, M.E., Clemmons, D.R., Malozowski, S. et al. (2006) Evaluation and treatment of adult growth hormone deficiency: an Endocrine Society Clinical Practice Guideline. Journal of Clinical Endocrinology and Metabolism, 91, 1621 1634.
32. Gutierrez, L.P., Koltowska-Haggstrom, M., Jonsson, P.J. et al. (2008) Registries as a tool in evidence-based medicine: example of KIMS (Pfizer International Metabolic Database). Pharmacoepidemiology and Drug Safety, 17, 90 102.
33. Chrisoulidou, A., Beshyah, S.A., Rutherford, O. et al. (2000) Effects of 7 years of growth hormone replacement therapy in hypopituitary adults. Journal of Clinical Endocrinology and Metabolism, 85, 3762 3769.
34. Piche, M.E., Arcand-Bosse, J.F., Despres, J.P. et al. (2004) What is a normal glucose value? Differences in indexes of plasma glucose homeostasis in subjects with normal fasting glucose. Diabetes Care, 27, 2470 2477.